LIfT successfully produces CAR-IMANs to further enhance alpha neutrophil cancer killing
LIfT BioSciences reports a substantial increase in cancer killing with the addition of a HER2 targeting CAR to its IMAN cell therapy...
top of page
LATEST NEWS
- Jul 6
LIfT BioSciences heralds a new era of affordable effective cancer cell therapies from iPSCs
- LIfT announces successful production of first-in-class neutrophil based cell therapy from iPSCs - Use of iPSCs will enable production...
- May 4
LIfT BioSciences announces data demonstrating potent killing of pancreatic cancer tumouroids
IMAN demonstrated potent direct killing of a patient derived pancreatic ductal adenocarcinoma tumouroid model IMAN is the world’s first...
bottom of page